The CPPC is a not-for-profit organisation which aims to promote policy that improves quality of life for those affected by chronic pain. The CPPC has been active in the pain arena for over ten years, with a parliamentary launch in June 2006 at Portcullis House, Westminster. Since then, the CPPC has worked to improve the lives of people with chronic pain and their families.
The CPPC is closely connected with other leading organisations in the pain environment, including the British Pain Society and the Faculty of Pain Medicine, which sits within the Royal College of Anaesthetists. The Pain Consortium brings together the CPPC, BPS and FPM to coordinate on activities and campaigns.
The CPPC is run by an advisory board of individuals with in-depth experience and expertise in chronic pain from a variety of disciplines including general practice, physiotherapy and many more. Co-Chairs Neil Betteridge and Martin Johnson set the strategic direction of the CPPC, with support from the advisory board. The CPPC is supported by Decideum, a market access and health policy consultancy, providing logistical support, and strategic input.
Neil’s onset of arthritis at the age of three had a serious impact on his childhood. He focused most of his career on representing the interests of patients in the UK and Europe. In 2011 he set up Neil Betteridge Associates (UK), an international consultancy offering patient insight to organisations that support people with chronic pain, rheumatic and musculoskeletal diseases and other long term conditions.
He is a long standing member of the EULAR Executive Committee, acting as EULAR’s Liaison Officer for Public Affairs, and has previously been its Vice President, representing the patient group network PARE, twice.
He also sits on the International Co-ordinating Council of the Global Alliance for Musculoskeletal Health; is a member of the 2019 Programme Committee for the EFIC Congress; acts as adviser to the European Alliance for Patient Access (EAfPA); is a Council member of the British Pain Society; and is a Patient Adviser to NHS England on Specialised Pain Services. Formerly he was CEO of the UK patient group Arthritis Care; Chair of the UK umbrella body for MSK, ARMA; Strategic Adviser, British Society for Rheumatology; Patient Adviser, Royal College of Physicians; and has been a UK ministerial adviser on both health and disability issues.
Dr Martin Johnson
For many years, after devoting much of his time to Primary Care Research (as a GP for 30 years), Martin developed a specific interest in the management of chronic pain.
Martin has written several articles regarding pain management, particularly focusing on neuropathic pain, the use of opioids and the organisation of pain services in the community.
In May 2018 Martin stepped down after 5 years on the British Pain Society Executive Group, initially as Secretary to the Council and then as Vice President (Membership). He remains on the British Pain Society Council as a representative member.
Martin is also College Representative at the RCGP lead for chronic pain (former Clinical Champion), Co-Chair of Chronic Pain Policy Coalition & Chair of Opioid Painkiller Dependence Alliance. Through these roles role he is trying to raise awareness of chronic pain and develop initiatives that will both enhance its management and also make it safer, especially with regard to opioid treatment.
Martin’s present employed role is as UK Medical Director to Synexus Ltd., which provides investigator sites for clinical research (including osteoarthritis & pain management studies).